Accelerating Belgian health-tech & biopharma innovation

About BioWin
iStock-1093656424-web5

See what’s happening in Wallonia, Belgium

Latest news & events

Learn more
Biowin-new-identity

BioWin launches new website, refreshes visual identity

    Corporate

28.01.2025

Learn more
Indianapolis-1872528

Sign up for AWEX and BioWin’s nuclear medicine mission this spring in the U.S. and Canada

    International Mission

08.01.2025

Learn more
getty-images-OPu3FqYgz5A-unsplash

Call 45 for collaborative R&D projects is open: Wallonia & Flanders team up for innovation!

    Funding Open calls

08.01.2025

Learn more
Science-for-health-website-post-thumbnail

Science for Health 2024: from innovation to implementation of AI and digitalisation in healthcare

    Press release

12.11.2024

Learn more

Annual Report 2023

    Corporate

03.07.2024

Learn more
BioWin-x-MEDVIA-1-1

BioWin and MEDVIA sign first strategic collaboration between health clusters in Wallonia and Flanders

    Collaboration Corporate

14.05.2024

Learn more
bioxodes2

Bioxodes secures new funds to reach early 2025 milestones and pursue Series B financing

    Press release

12.02.2025

Learn more
IBA

Framatome and IBA to partner to develop an Astatine-211 Cyclotron Network in Europe and the USA

    Press release

07.02.2025

Learn more

Hyloris Announces Partnership with Colonis Pharma for XTRAZA in the UK

    Press release

03.02.2025

Learn more
Novadip-NVD003-shipped-ready-for-the-implantation-to-the-patient

Novadip reports 12-month results from phase 1b/2a trial of NVD003 to treat rare pediatric disease Congenital Pseudarthrosis of the Tibia

    Press release

28.01.2025

Learn more
1630317185175

Bio-Sourcing SA announces the appointment of Maxime Wallerand as Chief Financial Officer

    Press release

24.01.2025

Learn more
Livedrop

LiveDrop-Bio unveils ModaFlow 4L5C: Revolutionizing biotherapeutic discovery with picoscale droplet technology

    Press release

08.01.2025

All news

Stay informed with the BioWin newsletter

Subscribe

Innovate

Why join BioWin

We help simplify the path to bringing innovative ideas to life. With nearly 20 years of hands-on collaborative innovation experience, we don’t just connect companies, research centers, hospitals, and academic institutions—we’re a true partner, offering real support at every step of the research and development process.

From shaping your project to sourcing its financing and ensuring it stays on track, that’s how we give health-tech and biopharma innovations their greatest chance of success.

Learn more
iStock-542576976

Connect

Why join BioWin

In a bid to increase opportunities for our members in terms of both collaboration and market expansion, we connect them to partners through regular events. We also seek to enhance sector attractiveness to source the future talent needed to create sustainable innovation across the Walloon Region.

 

Learn more
iStock-530685719

Communicate

Why join BioWin

Our targeted communication strategies aim to strengthen Wallonia’s profile, while maximising our members’ presence both locally and globally.

Learn more
getty-images-B1n_PGHf4JA-unsplash

Operating at the epicentre of regional health-tech & biopharma innovation

What we work on

Biopharma

iStock-1289345741

Health-tech

iStock-1125084447-web
  • From championing collaborative innovation to playing a more global role in the implementation of the sector’s industrial policy, making innovation happen is part of our DNA.
  • We aim to increase the competitiveness of the Walloon region in the biopharma and health-tech sectors by identifying and supporting strategic projects and portfolios for the benefit of our members and the patients they serve.
  • BioWin’s network of 260+ world-class organisations is an exceptional ecosystem known for both its academic excellence and robust industrial value chain in biomanufacturing, advanced therapies, nuclear medicine and medical technologies. 

Our ecosystem at a glance

Numbers

Our ecosystem

264

supported organisations

89

supported R&D projects

313,74M

€ raised by our members through public-private funding

3

job offers